(Inclusive of all Taxes)
Get Free delivery (₹99)
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Have a query?
Drug-Drug Interactions
Critical
AmlodipineDantrolene
Critical
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Olmtan AH 20mg/5mg/12.5mg Tablet:
Using aliskiren together with olmesartan may increase the risk of serious side effects (kidney problems, low blood pressure, and high potassium levels in the blood).
How to manage the interaction:
Taking Olmtan AH 20mg/5mg/12.5mg Tablet with Aliskiren is not recommended as it can cause an interaction, they can be taken if advised by a doctor. You should seek medical attention if you experience nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat.It is crucial that you continue to consume enough fluids while taking these medications. Do not stop using any medications without consulting a doctor.
Using aliskiren together with olmesartan may increase the risk of serious side effects (kidney problems, low blood pressure, and high potassium levels in the blood).
How to manage the interaction:
Taking Olmtan AH 20mg/5mg/12.5mg Tablet with Aliskiren is not recommended as it can cause an interaction, they can be taken if advised by a doctor. You should seek medical attention if you experience nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat.It is crucial that you continue to consume enough fluids while taking these medications. Do not stop using any medications without consulting a doctor.
AmlodipineDantrolene
Critical
How does the drug interact with Olmtan AH 20mg/5mg/12.5mg Tablet:
Using Olmtan AH 20mg/5mg/12.5mg Tablet together with dantrolene may increase the risk of hyperkalemia (high blood potassium).
How to manage the interaction:
Taking Olmtan AH 20mg/5mg/12.5mg Tablet with Dantrolene can cause an interaction, consult a doctor before taking it. You should seek medical attention if you experience nausea, vomiting, weakness, confusion, tingling of the hands and feet, a weak pulse, or a slow or irregular heartbeat. Do not stop using any medications without talking to a doctor.
Using Olmtan AH 20mg/5mg/12.5mg Tablet together with dantrolene may increase the risk of hyperkalemia (high blood potassium).
How to manage the interaction:
Taking Olmtan AH 20mg/5mg/12.5mg Tablet with Dantrolene can cause an interaction, consult a doctor before taking it. You should seek medical attention if you experience nausea, vomiting, weakness, confusion, tingling of the hands and feet, a weak pulse, or a slow or irregular heartbeat. Do not stop using any medications without talking to a doctor.
Critical
How does the drug interact with Olmtan AH 20mg/5mg/12.5mg Tablet:
Taking Cisapride and Olmtan AH 20mg/5mg/12.5mg Tablet can increase the risk of an irregular heart rhythm which can be severe. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Combining Cisapride and Olmtan AH 20mg/5mg/12.5mg Tablet together is generally avoided as it can possibly result in an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like dizziness, lightheadedness, fainting, or fast or pounding heartbeats, consult the doctor immediately. Do not stop using any medications without a doctor's advice.
Taking Cisapride and Olmtan AH 20mg/5mg/12.5mg Tablet can increase the risk of an irregular heart rhythm which can be severe. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Combining Cisapride and Olmtan AH 20mg/5mg/12.5mg Tablet together is generally avoided as it can possibly result in an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like dizziness, lightheadedness, fainting, or fast or pounding heartbeats, consult the doctor immediately. Do not stop using any medications without a doctor's advice.
HydrochlorothiazideDofetilide
Critical
How does the drug interact with Olmtan AH 20mg/5mg/12.5mg Tablet:
Taking Dofetilide and Olmtan AH 20mg/5mg/12.5mg Tablet can increase the risk of an irregular heart rhythm which can be severe. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Combining Dofetilide and Olmtan AH 20mg/5mg/12.5mg Tablet together is not recommended as it can possibly result in an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like sudden dizziness, lightheadedness, fainting, shortness of breath, chest pain or tightness, rapid heartbeat, or memory loss, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
Taking Dofetilide and Olmtan AH 20mg/5mg/12.5mg Tablet can increase the risk of an irregular heart rhythm which can be severe. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Combining Dofetilide and Olmtan AH 20mg/5mg/12.5mg Tablet together is not recommended as it can possibly result in an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like sudden dizziness, lightheadedness, fainting, shortness of breath, chest pain or tightness, rapid heartbeat, or memory loss, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
How does the drug interact with Olmtan AH 20mg/5mg/12.5mg Tablet:
Taking Amiloride with Olmtan AH 20mg/5mg/12.5mg Tablet can elevate potassium levels in the blood. (High potassium levels can cause hyperkalemia, which can lead to kidney failure, muscular paralysis, abnormal heart rhythm, and cardiac arrest in extreme cases).
How to manage the interaction:
Although taking amiloride with Olmtan AH 20mg/5mg/12.5mg Tablet may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is important to maintain proper fluid intake while taking these medications. Do not stop using any medications without talking to a doctor.
Taking Amiloride with Olmtan AH 20mg/5mg/12.5mg Tablet can elevate potassium levels in the blood. (High potassium levels can cause hyperkalemia, which can lead to kidney failure, muscular paralysis, abnormal heart rhythm, and cardiac arrest in extreme cases).
How to manage the interaction:
Although taking amiloride with Olmtan AH 20mg/5mg/12.5mg Tablet may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is important to maintain proper fluid intake while taking these medications. Do not stop using any medications without talking to a doctor.
Olmesartan medoxomilTriamterene
Severe
How does the drug interact with Olmtan AH 20mg/5mg/12.5mg Tablet:
Taking Olmtan AH 20mg/5mg/12.5mg Tablet with triamterene may increase potassium levels in the blood. (High potassium levels can cause hyperkalemia, which can lead to kidney failure, muscular paralysis, abnormal heart rhythm, and cardiac arrest in extreme cases).
How to manage the interaction:
Although taking Olmtan AH 20mg/5mg/12.5mg Tablet with triamterene may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. Do not stop using any medications without talking to a doctor.
Taking Olmtan AH 20mg/5mg/12.5mg Tablet with triamterene may increase potassium levels in the blood. (High potassium levels can cause hyperkalemia, which can lead to kidney failure, muscular paralysis, abnormal heart rhythm, and cardiac arrest in extreme cases).
How to manage the interaction:
Although taking Olmtan AH 20mg/5mg/12.5mg Tablet with triamterene may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. Do not stop using any medications without talking to a doctor.
How does the drug interact with Olmtan AH 20mg/5mg/12.5mg Tablet:
Taking ramipril together with olmesartan may increase the risk of side effects (blood pressure, kidney function impairment, and a condition called Hyperkalemia - high blood potassium).
How to manage the interaction:
Although taking Olmtan AH 20mg/5mg/12.5mg Tablet with ramipril may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. Do not stop using any medications without talking to a doctor.
Taking ramipril together with olmesartan may increase the risk of side effects (blood pressure, kidney function impairment, and a condition called Hyperkalemia - high blood potassium).
How to manage the interaction:
Although taking Olmtan AH 20mg/5mg/12.5mg Tablet with ramipril may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. Do not stop using any medications without talking to a doctor.
How does the drug interact with Olmtan AH 20mg/5mg/12.5mg Tablet:
Using Olmtan AH 20mg/5mg/12.5mg Tablet with Potassium chloride may increase Potassium levels in the blood.
How to manage the interaction:
Although taking Olmtan AH 20mg/5mg/12.5mg Tablet together with Potassium chloride may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is important to maintain proper fluid intake while taking these medications. Do not stop using any medications without talking to a doctor.
Using Olmtan AH 20mg/5mg/12.5mg Tablet with Potassium chloride may increase Potassium levels in the blood.
How to manage the interaction:
Although taking Olmtan AH 20mg/5mg/12.5mg Tablet together with Potassium chloride may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is important to maintain proper fluid intake while taking these medications. Do not stop using any medications without talking to a doctor.
Olmesartan medoxomilPotassium citrate
Severe
How does the drug interact with Olmtan AH 20mg/5mg/12.5mg Tablet:
Coadministration of Olmtan AH 20mg/5mg/12.5mg Tablet may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Olmtan AH 20mg/5mg/12.5mg Tablet together with potassium citrate may result in an interaction, they can be taken together if prescribed by your doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. Do not discontinue any medications without a doctor's advice.
Coadministration of Olmtan AH 20mg/5mg/12.5mg Tablet may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Olmtan AH 20mg/5mg/12.5mg Tablet together with potassium citrate may result in an interaction, they can be taken together if prescribed by your doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. Do not discontinue any medications without a doctor's advice.
Olmesartan medoxomilpotassium phosphate
Severe
How does the drug interact with Olmtan AH 20mg/5mg/12.5mg Tablet:
Using potassium phosphate together with olmesartan may significantly increase potassium levels in the blood.
How to manage the interaction:
Although taking Olmtan AH 20mg/5mg/12.5mg Tablet and potassium phosphate together can cause an interaction, it can be taken if a doctor has suggested it. However if you experience symptoms such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat, consult a doctor. It is crucial that you continue to consume enough fluids while taking these medications. Do not discontinue any medications without consulting a doctor.
Using potassium phosphate together with olmesartan may significantly increase potassium levels in the blood.
How to manage the interaction:
Although taking Olmtan AH 20mg/5mg/12.5mg Tablet and potassium phosphate together can cause an interaction, it can be taken if a doctor has suggested it. However if you experience symptoms such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat, consult a doctor. It is crucial that you continue to consume enough fluids while taking these medications. Do not discontinue any medications without consulting a doctor.
Drug-Food Interactions
AMLODIPINE-5MG+HYDROCHLOROTHIAZIDE-12.5MG+OLMESARTAN MEDOXOMIL-20MGPotassium rich foods
Moderate
Drug-Food Interactions
Login/Sign Up
AMLODIPINE-5MG+HYDROCHLOROTHIAZIDE-12.5MG+OLMESARTAN MEDOXOMIL-20MGPotassium rich foods
Moderate
Common Foods to Avoid:
Lentils, Orange Juice, Oranges, Raisins, Potatoes, Salmon Dried, Spinach, Sweet Potatoes, Tomatoes, Coconut Water, Beans, Beetroot, Broccoli, Bananas, Apricots, Avocado, Yogurt
How to manage the interaction:
Taking Olmtan AH 20mg/5mg/12.5mg Tablet with potassium-containing salt substitutes or potassium supplements can cause high levels of potassium in the blood. Avoid taking potassium-containing salt substitutes or potassium supplements while being treated with Olmtan AH 20mg/5mg/12.5mg Tablet.
Lentils, Orange Juice, Oranges, Raisins, Potatoes, Salmon Dried, Spinach, Sweet Potatoes, Tomatoes, Coconut Water, Beans, Beetroot, Broccoli, Bananas, Apricots, Avocado, Yogurt
How to manage the interaction:
Taking Olmtan AH 20mg/5mg/12.5mg Tablet with potassium-containing salt substitutes or potassium supplements can cause high levels of potassium in the blood. Avoid taking potassium-containing salt substitutes or potassium supplements while being treated with Olmtan AH 20mg/5mg/12.5mg Tablet.
ओल्मटैन एएच 20mg/5mg/12.5mg टैबलेट Substitute
Olmetime AMH 20 Tablet 10's
by Others
₹11.57per tabletTriolmighty 20 Tablet 10's
by Others
₹12.24per tabletOlmedawn Trio 20/5/12.5 Tablet 10's
by Others
₹13.77per tabletOlmin 20-AH Tablet 10's
by Others
₹15.75per tabletOlmat-20 AMH Tablet 15's
by Others
₹16.20per tablet
शराब
असुरक्षित
आपको सलाह दी जाती है कि आप शराब का सेवन न करें और ओल्मटैन एएच 20mg/5mg/12.5mg टैबलेट ताकि उनींदापन, चक्कर आना और लीवर खराब होने जैसे अप्रिय दुष्प्रभावों से बचा जा सके।
गर्भावस्था
असुरक्षित
ओल्मटैन एएच 20mg/5mg/12.5mg टैबलेट गर्भावस्था के दौरान अनुशंसित नहीं है क्योंकि इसमें ओल्मेसार्टन होता है, जो एक श्रेणी डी गर्भावस्था दवा है। यह दवा भ्रूण को नुकसान पहुंचा सकती है और अजन्मे बच्चे (भ्रूण) को प्रभावित कर सकती है।
स्तनपान
असुरक्षित
ओल्मटैन एएच 20mg/5mg/12.5mg टैबलेट स्तन के दूध में जाने के लिए जाना जाता है, लेकिन बच्चे पर इसका प्रभाव अज्ञात है। इसलिए, स्तनपान कराने से पहले, अपने डॉक्टर को इसके बारे में बताएं। या तो आपको ओल्मटैन एएच 20mg/5mg/12.5mg टैबलेट का उपयोग करने के लिए स्तनपान बंद करने की आवश्यकता है या ओल्मटैन एएच 20mg/5mg/12.5mg टैबलेट लेना बंद कर दें।
ड्राइविंग
सावधानी
सावधानी से गाड़ी चलाएं; ओल्मटैन एएच 20mg/5mg/12.5mg टैबलेट आमतौर पर उनींदापन का कारण बनता है और ड्राइविंग क्षमता को प्रभावित करता है।
जिगर
सावधानी
ओल्मटैन एएच 20mg/5mg/12.5mg टैबलेट सावधानी के साथ लेना है, खासकर यदि आपको लीवर की बीमारी है या पहले कभी हुई है। आपका डॉक्टर आपकी चिकित्सा स्थिति और उपचार के प्रति आपकी प्रतिक्रिया के आधार पर खुराक को बदल देगा।
गुर्दा
सावधानी
ओल्मटैन एएच 20mg/5mg/12.5mg टैबलेट सावधानी के साथ लेना है, खासकर यदि आपको गुर्दे की बीमारी का इतिहास रहा है। आपका डॉक्टर आपकी चिकित्सा स्थिति और उपचार के प्रति आपकी प्रतिक्रिया के आधार पर खुराक को बदल देगा।
बच्चे
सावधानी
बच्चों में ओल्मटैन एएच 20mg/5mg/12.5mg टैबलेट की प्रभावकारिता और सुरक्षा स्थापित नहीं की गई है। यदि निर्धारित किया गया है, तो यह सख्ती से चिकित्सकीय देखरेख में होना चाहिए और केवल तभी जब लाभ नुकसान से अधिक हो।
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
